Your browser doesn't support javascript.
loading
A window-of-opportunity clinical trial of dasatinib in women with newly diagnosed endometrial cancer.
Duska, Linda R; Petroni, Gina R; Lothamer, Heather; Faust, William; Beumer, Jan H; Christner, Susan M; Mills, Anne M; Fracasso, Paula M; Parsons, Sarah J.
Afiliação
  • Duska LR; Department of Obstetrics and Gynecology, Division of Gynecology Oncology, University of Virginia School of Medicine, Charlottesville, VA, USA. lduska@virginia.edu.
  • Petroni GR; University of Virginia Cancer Center, Charlottesville, VA, USA. lduska@virginia.edu.
  • Lothamer H; Department of Public Health Services, University of Virginia School of Medicine, Charlottesville, VA, USA.
  • Faust W; University of Virginia Cancer Center, Charlottesville, VA, USA.
  • Beumer JH; Department of Obstetrics and Gynecology, Division of Gynecology Oncology, University of Virginia School of Medicine, Charlottesville, VA, USA.
  • Christner SM; University of Virginia Cancer Center, Charlottesville, VA, USA.
  • Mills AM; Department of Microbiology, Immunology, and Cancer Biology, University of Virginia School of Medicine, Charlottesville, VA, USA.
  • Fracasso PM; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.
  • Parsons SJ; Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Cancer Chemother Pharmacol ; 83(3): 473-482, 2019 03.
Article em En | MEDLINE | ID: mdl-30535536

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Neoplasias do Endométrio / Quinases da Família src / Inibidores de Proteínas Quinases / Dasatinibe Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Neoplasias do Endométrio / Quinases da Família src / Inibidores de Proteínas Quinases / Dasatinibe Idioma: En Ano de publicação: 2019 Tipo de documento: Article